Papers published in national and international conferences or symposium proceedings (8)

  1. 4. Vandenbempt, V., Elvira Jimenez, B., Bauzá-Martinez, J., Negueruela Escudero, J., Ibrahim, H., Winder, M. M., Vekeriotaite, B., Singh, S. P., Rossello, F., Lybaert, P., Otonkoski, T., Gysemans, C., Wu, W., & Gurzov, E. N. (2021). PTPN2 regulates the interferon signalling in pancreatic beta-cells and its expression correlates with therapy outcome in autoimmune diabetes.
  2. 5. Schaschkow, A., Pang, L., Litwak, S. S., Paula, F. M., Eizirik, D. L., Marchetti, P., Gough, D. D., Gurzov, E. N., et al. (2020). Mitochondrial STAT3 contributes to pancreatic beta cell adaptation in obesity. Diabetologia
  3. 6. Elvira Jimenez, B., Vandenbempt, V., & Gurzov, E. N. (2020). Ptpn2 is a pro-inflammatory cytokine regulator and novel player in the endoplasmic reticulum stress response in beta cells. Diabetologia
  4. 7. Santin Gomez, I., Moore, F., Colli, M. L., Gurzov, E. N., & Eizirik, D. L. (2011). PTPN2, a candidate gene for type 1 diabetes, modulates pancreatic beta cell apoptosis via regulation of the BH3-only protein Bim. Diabetologia.
  5. 8. Colli, M. L., Moore, F., Gurzov, E. N., Ortis, F., & Eizirik, D. L. (2009). PTPN2 and MDA5, two candidate genes for type 1 diabetes, modify beta cell responses to double-stranded RNA. Diabetologia.
  6.   Active participation in international conferences and symposiums (25)

  7. 1. Gurzov, E. N. (2023). Targeting tyrosine phosphatases in obesity-associated liver dysfunction – on the right track or a lost cause? Signal regulation by protein phosphatases: Mechanisms and pathways Abstract session presented at EMBO Workshop(6-10 August 2023: Copenhagen)
  8. 2. Gurzov, E. N. (2019). A Role for Beta-Cell Protein Tyrosine Phosphatases in the Pathogenesis of Type 1 Diabetes . Paper session presented at 79th Scientific Sessions American Diabetes Association (07-11 June 2019: San Francisco, USA).
  9. 3. Gurzov, E. N. (2018). The Role of Protein Tyrosine Phosphatases in Metabolic Diseases. Paper session presented at Jornadas SEJI Jovenes Investigadores de Excelencia: new approaches in diabetes research (30th November, 2018: Alicante, Spain).
  10. 4. Gurzov, E. N., et al. (2016). Hepatic BCL-2-interacting-mediator-of-cell-death (BIM) deficiency improves mitochondrial function, decreases oxidate stress and enhances insulin sensitivity in diet-induced obesity. Paper session presented at Metabolic Diseases: Breakthrough Discoveries in Diabetes and Obesity 2016 (Melbourne-Australia).
  11. 5. Stanley, W. W., Thomas, H. H., & Gurzov, E. N. (2016). PTPN6, a novel regulator of TNF-alpha induced cell death in beta cells. Paper session presented at The Australian Islet Study Group Meeting 2016 (Melbourne-Australia).
  12. 6. Gurzov, E. N., et al. (2016). p53-upregulated-modulator-of-apoptosis (PUMA) deficiency affects food intake, adipocyte size and leptin levels in diet-induced obesity. Poster session presented at 17th International Congress of Endocrinology in collaboration with the 15th Annual Meeting of the Chinese Society of Endocrinology 2016 (Beijing-China).
  13. 7. Stanley, W. W., Thomas, H. H., & Gurzov, E. N. (2016). PTPN1, a novel target for limiting interferon signalling in beta cells to protect against autoimmune diabetes. Paper session presented at ADS & ADEA annual meeting 2016 (Gold Coast-Australia).

  14. << Previous 1 2 3 4 5 6 7 8 Next >>